Suchergebnisse - "Arribas, José Ramón"

PubPharm (119)

1

Epidemiological characteristic and prognosis changes in chronic hepatitis B in people living with HIV

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2024

von Vásquez Manau, J. | Marcelo Calvo, C. | De Gea Grela, A. | +13

2

Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV

enthalten in: HIV medicine | 2024

von Ramos-Ruperto, L. | Arcos-Rueda, M. | de Miguel-Buckley, R. | +11

3

COVID-19 Clinical Trials : Are Adaptive Methodologies the Solution?

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Montejano, R. | Arribas, J.

4

Treatment and prevention of monkeypox

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2023

von de la Calle-Prieto, F. | Estébanez Muñoz, M. | Ramírez, G. | +12

5

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von González-Cordón, A. | Assoumou, L. | Moyle, G. | +117

6

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk : A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waters, L. | Assoumou, L. | González-Cordón, A. | +121

7

Corrigendum to "Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine : 48-week results of a non-randomized, pilot clinical trial (ART-PRO)"

enthalten in: EBioMedicine | 2023

von De Miguel, R. | Rial-Crestelo, D. | Dominguez-Dominguez, L. | +20

ErratumFor: EBioMedicine. 2020 May;55:102779. - PMID 32408111

8

No changes in hemostasis after COVID-19-heterologous vaccination schedule : A subanalysis of the phase 2 CombiVacS study

enthalten in: Research and practice in thrombosis and haemostasis | 2023

von Butta, N. | Arias-Salgado, E. | Monzón Manzano, E. | +15

9

Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19 : a double-blind placebo-controlled randomized trial in healthcare workers

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Polo, R. | García-Albéniz, X. | Terán, C. | +33

10

Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection

enthalten in: AIDS (London, England) | 2022

von Del Amo, J. | Polo, R. | Moreno, S. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]